25 XP   0   0   10

China National Medicines Corp Ltd
Buy, Hold or Sell?

Let's analyse China National Medicines Corp Ltd together

PenkeI guess you are interested in China National Medicines Corp Ltd. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of China National Medicines Corp Ltd. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about China National Medicines Corp Ltd

I send you an email if I find something interesting about China National Medicines Corp Ltd.

Quick analysis of China National Medicines Corp Ltd (30 sec.)










What can you expect buying and holding a share of China National Medicines Corp Ltd? (30 sec.)

How much money do you get?

How much money do you get?
¥0.13
When do you have the money?
1 year
How often do you get paid?
100.0%

What is your share worth?

Current worth
¥23.24
Expected worth in 1 year
¥25.46
How sure are you?
97.5%

+ What do you gain per year?

Total Gains per Share
¥3.16
Return On Investment
9.6%

For what price can you sell your share?

Current Price per Share
¥33.00
Expected price per share
¥27.18 - ¥33.75
How sure are you?
50%

1. Valuation of China National Medicines Corp Ltd (5 min.)




Live pricePrice per Share (EOD)

¥33.00

Intrinsic Value Per Share

¥66.04 - ¥161.14

Total Value Per Share

¥89.28 - ¥184.38

2. Growth of China National Medicines Corp Ltd (5 min.)




Is China National Medicines Corp Ltd growing?

Current yearPrevious yearGrowGrow %
How rich?$2.4b$2b$218.3m9.4%

How much money is China National Medicines Corp Ltd making?

Current yearPrevious yearGrowGrow %
Making money$74.2m$67.9m$6.2m8.5%
Net Profit Margin4.3%4.3%--

How much money comes from the company's main activities?

3. Financial Health of China National Medicines Corp Ltd (5 min.)




4. Comparing to competitors in the Medical Distribution industry (5 min.)




  Industry Rankings (Medical Distribution)  

What can you expect buying and holding a share of China National Medicines Corp Ltd? (5 min.)

Welcome investor! China National Medicines Corp Ltd's management wants to use your money to grow the business. In return you get a share of China National Medicines Corp Ltd.

What can you expect buying and holding a share of China National Medicines Corp Ltd?

First you should know what it really means to hold a share of China National Medicines Corp Ltd. And how you can make/lose money.

Speculation

The Price per Share of China National Medicines Corp Ltd is ¥33.00. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of China National Medicines Corp Ltd.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in China National Medicines Corp Ltd, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is ¥23.24. Based on the TTM, the Book Value Change Per Share is ¥0.55 per quarter. Based on the YOY, the Book Value Change Per Share is ¥0.50 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is ¥0.24 per quarter.
Based on historical numbers we can estimate the returns while holding a share of China National Medicines Corp Ltd.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 ¥% of Price per Share¥% of Price per Share¥% of Price per Share¥% of Price per Share¥% of Price per Share
Usd Eps0.130.4%0.100.3%0.090.3%0.080.2%0.060.2%
Usd Book Value Change Per Share0.130.4%0.080.2%0.070.2%0.100.3%0.070.2%
Usd Dividend Per Share0.000.0%0.030.1%0.030.1%0.030.1%0.020.1%
Usd Total Gains Per Share0.140.4%0.110.3%0.100.3%0.130.4%0.090.3%
Usd Price Per Share3.96-4.77-3.77-4.43-4.31-
Price to Earnings Ratio7.90-12.70-10.82-16.27-26.35-
Price-to-Total Gains Ratio28.72-45.24-38.62-55.00-76.15-
Price to Book Ratio1.23-1.56-1.36-1.95-3.92-
Price-to-Total Gains Ratio28.72-45.24-38.62-55.00-76.15-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share4.5672
Number of shares218
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.030.03
Usd Book Value Change Per Share0.080.10
Usd Total Gains Per Share0.110.13
Gains per Quarter (218 shares)23.8328.68
Gains per Year (218 shares)95.30114.73
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
12867852391105
25713418047183220
38520127570274335
411326837093366450
5142335465117457565
6170402560140548680
7199468655163640795
8227535750187731910
92556028452108221025
102846699402339141140

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share4.00.00.0100.0%12.00.00.0100.0%20.00.00.0100.0%40.00.00.0100.0%84.00.00.0100.0%
Book Value Change Per Share4.00.00.0100.0%11.01.00.091.7%18.02.00.090.0%37.03.00.092.5%78.06.00.092.9%
Dividend per Share4.00.00.0100.0%12.00.00.0100.0%20.00.00.0100.0%40.00.00.0100.0%80.00.04.095.2%
Total Gains per Share4.00.00.0100.0%12.00.00.0100.0%20.00.00.0100.0%39.01.00.097.5%83.01.00.098.8%

Fundamentals of China National Medicines Corp Ltd

About China National Medicines Corp Ltd

China National Medicines Corporation Ltd., together with its subsidiaries, distributes pharmaceutical products in China. The company also manufactures and sells new drugs and finished drugs; sells Chinese patent medicines and western medicines, and medical equipment; and offers warehousing and import and export agency services. It serves hospitals, retail pharmacies, and medical institutions. The company was founded in 1999 and is based in Beijing, China.

Fundamental data was last updated by Penke on 2024-03-26 18:08:08.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a profit.
Using its assets, the company is less efficient in making profit.
Using its investors money, the company is inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating less efficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is able to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is underpriced.
Based on the earnings, the company is underpriced.
Based on how much money comes from the company's main activities, the company is cheap.

1.1. Profitability of China National Medicines Corp Ltd.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit China National Medicines Corp Ltd earns for each ¥1 of revenue.

  • Above 10% is considered healthy but always compare China National Medicines Corp Ltd to the Medical Distribution industry mean.
  • A Net Profit Margin of 5.2% means that ¥0.05 for each ¥1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of China National Medicines Corp Ltd:

  • The MRQ is 5.2%. The company is making a profit. +1
  • The TTM is 4.3%. The company is making a profit. +1
Trends
Current periodCompared to+/- 
MRQ5.2%TTM4.3%+0.9%
TTM4.3%YOY4.3%0.0%
TTM4.3%5Y3.9%+0.4%
5Y3.9%10Y3.9%0.0%
Compared to industry (Medical Distribution)
PeriodCompanyIndustry (mean)+/- 
MRQ5.2%1.9%+3.3%
TTM4.3%2.2%+2.1%
YOY4.3%2.4%+1.9%
5Y3.9%2.2%+1.7%
10Y3.9%2.1%+1.8%
1.1.2. Return on Assets

Shows how efficient China National Medicines Corp Ltd is using its assets to generate profit.

  • Above 5% is considered healthy but always compare China National Medicines Corp Ltd to the Medical Distribution industry mean.
  • 2.1% Return on Assets means that China National Medicines Corp Ltd generated ¥0.02 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of China National Medicines Corp Ltd:

  • The MRQ is 2.1%. Using its assets, the company is less efficient in making profit.
  • The TTM is 1.7%. Using its assets, the company is less efficient in making profit.
Trends
Current periodCompared to+/- 
MRQ2.1%TTM1.7%+0.4%
TTM1.7%YOY1.7%0.0%
TTM1.7%5Y1.7%+0.1%
5Y1.7%10Y1.8%-0.2%
Compared to industry (Medical Distribution)
PeriodCompanyIndustry (mean)+/- 
MRQ2.1%0.8%+1.3%
TTM1.7%0.9%+0.8%
YOY1.7%0.8%+0.9%
5Y1.7%0.9%+0.8%
10Y1.8%1.0%+0.8%
1.1.3. Return on Equity

Shows how efficient China National Medicines Corp Ltd is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare China National Medicines Corp Ltd to the Medical Distribution industry mean.
  • 4.3% Return on Equity means China National Medicines Corp Ltd generated ¥0.04 for each ¥1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of China National Medicines Corp Ltd:

  • The MRQ is 4.3%. Using its investors money, the company is inefficient in making profit. -1
  • The TTM is 3.6%. Using its investors money, the company is inefficient in making profit. -1
Trends
Current periodCompared to+/- 
MRQ4.3%TTM3.6%+0.8%
TTM3.6%YOY3.6%-0.1%
TTM3.6%5Y3.6%0.0%
5Y3.6%10Y4.0%-0.4%
Compared to industry (Medical Distribution)
PeriodCompanyIndustry (mean)+/- 
MRQ4.3%2.1%+2.2%
TTM3.6%2.5%+1.1%
YOY3.6%2.2%+1.4%
5Y3.6%2.3%+1.3%
10Y4.0%2.4%+1.6%

1.2. Operating Efficiency of China National Medicines Corp Ltd.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient China National Medicines Corp Ltd is operating .

  • Measures how much profit China National Medicines Corp Ltd makes for each ¥1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare China National Medicines Corp Ltd to the Medical Distribution industry mean.
  • An Operating Margin of 0.0% means the company generated ¥0.00  for each ¥1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of China National Medicines Corp Ltd:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM2.2%-2.2%
TTM2.2%YOY4.9%-2.7%
TTM2.2%5Y4.2%-2.0%
5Y4.2%10Y2.3%+1.9%
Compared to industry (Medical Distribution)
PeriodCompanyIndustry (mean)+/- 
MRQ-3.1%-3.1%
TTM2.2%2.6%-0.4%
YOY4.9%3.5%+1.4%
5Y4.2%3.3%+0.9%
10Y2.3%2.0%+0.3%
1.2.2. Operating Ratio

Measures how efficient China National Medicines Corp Ltd is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Medical Distribution industry mean).
  • An Operation Ratio of 1.86 means that the operating costs are ¥1.86 for each ¥1 in net sales.

Let's take a look of the Operating Ratio trends of China National Medicines Corp Ltd:

  • The MRQ is 1.856. The company is inefficient in keeping operating costs low. -1
  • The TTM is 1.871. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ1.856TTM1.871-0.015
TTM1.871YOY1.863+0.007
TTM1.8715Y1.870+0.001
5Y1.87010Y1.441+0.429
Compared to industry (Medical Distribution)
PeriodCompanyIndustry (mean)+/- 
MRQ1.8561.369+0.487
TTM1.8711.369+0.502
YOY1.8631.413+0.450
5Y1.8701.312+0.558
10Y1.4411.210+0.231

1.3. Liquidity of China National Medicines Corp Ltd.

1.3. Liquidity
1.3.1. Current Ratio

Measures if China National Medicines Corp Ltd is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Medical Distribution industry mean).
  • A Current Ratio of 2.04 means the company has ¥2.04 in assets for each ¥1 in short-term debts.

Let's take a look of the Current Ratio trends of China National Medicines Corp Ltd:

  • The MRQ is 2.035. The company is able to pay all its short-term debts. +1
  • The TTM is 2.019. The company is able to pay all its short-term debts. +1
Trends
Current periodCompared to+/- 
MRQ2.035TTM2.019+0.016
TTM2.019YOY1.993+0.026
TTM2.0195Y1.951+0.068
5Y1.95110Y1.066+0.886
Compared to industry (Medical Distribution)
PeriodCompanyIndustry (mean)+/- 
MRQ2.0351.366+0.669
TTM2.0191.418+0.601
YOY1.9931.403+0.590
5Y1.9511.408+0.543
10Y1.0661.299-0.233
1.3.2. Quick Ratio

Measures if China National Medicines Corp Ltd is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare China National Medicines Corp Ltd to the Medical Distribution industry mean.
  • A Quick Ratio of 0.64 means the company can pay off ¥0.64 for each ¥1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of China National Medicines Corp Ltd:

  • The MRQ is 0.645. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 0.670. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ0.645TTM0.670-0.026
TTM0.670YOY1.112-0.442
TTM0.6705Y0.997-0.327
5Y0.99710Y0.985+0.013
Compared to industry (Medical Distribution)
PeriodCompanyIndustry (mean)+/- 
MRQ0.6450.758-0.113
TTM0.6700.757-0.087
YOY1.1120.828+0.284
5Y0.9970.814+0.183
10Y0.9850.850+0.135

1.4. Solvency of China National Medicines Corp Ltd.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of China National Medicines Corp Ltd assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare China National Medicines Corp Ltd to Medical Distribution industry mean.
  • A Debt to Asset Ratio of 0.46 means that China National Medicines Corp Ltd assets are financed with 46.0% credit (debt) and the remaining percentage (100% - 46.0%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of China National Medicines Corp Ltd:

  • The MRQ is 0.460. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.464. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.460TTM0.464-0.004
TTM0.464YOY0.465-0.001
TTM0.4645Y0.478-0.014
5Y0.47810Y0.490-0.012
Compared to industry (Medical Distribution)
PeriodCompanyIndustry (mean)+/- 
MRQ0.4600.617-0.157
TTM0.4640.606-0.142
YOY0.4650.608-0.143
5Y0.4780.610-0.132
10Y0.4900.593-0.103
1.4.2. Debt to Equity Ratio

Measures if China National Medicines Corp Ltd is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare China National Medicines Corp Ltd to the Medical Distribution industry mean.
  • A Debt to Equity ratio of 94.6% means that company has ¥0.95 debt for each ¥1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of China National Medicines Corp Ltd:

  • The MRQ is 0.946. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.964. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.946TTM0.964-0.018
TTM0.964YOY0.973-0.009
TTM0.9645Y1.039-0.075
5Y1.03910Y1.084-0.045
Compared to industry (Medical Distribution)
PeriodCompanyIndustry (mean)+/- 
MRQ0.9461.698-0.752
TTM0.9641.678-0.714
YOY0.9731.752-0.779
5Y1.0391.733-0.694
10Y1.0841.738-0.654

2. Market Valuation of China National Medicines Corp Ltd

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every ¥1 in earnings China National Medicines Corp Ltd generates.

  • Above 15 is considered overpriced but always compare China National Medicines Corp Ltd to the Medical Distribution industry mean.
  • A PE ratio of 7.90 means the investor is paying ¥7.90 for every ¥1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of China National Medicines Corp Ltd:

  • The EOD is 9.104. Based on the earnings, the company is underpriced. +1
  • The MRQ is 7.896. Based on the earnings, the company is underpriced. +1
  • The TTM is 12.698. Based on the earnings, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD9.104MRQ7.896+1.208
MRQ7.896TTM12.698-4.802
TTM12.698YOY10.819+1.879
TTM12.6985Y16.268-3.570
5Y16.26810Y26.355-10.087
Compared to industry (Medical Distribution)
PeriodCompanyIndustry (mean)+/- 
EOD9.10413.475-4.371
MRQ7.89614.623-6.727
TTM12.69818.845-6.147
YOY10.81918.249-7.430
5Y16.26817.230-0.962
10Y26.35519.682+6.673
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of China National Medicines Corp Ltd:

  • The EOD is 2.331. Based on how much money comes from the company's main activities, the company is cheap. +2
  • The MRQ is 2.022. Based on how much money comes from the company's main activities, the company is cheap. +2
  • The TTM is 11.810. Based on how much money comes from the company's main activities, the company is cheap. +2
Trends
Current periodCompared to+/- 
EOD2.331MRQ2.022+0.309
MRQ2.022TTM11.810-9.789
TTM11.810YOY-3.743+15.553
TTM11.8105Y2.183+9.627
5Y2.18310Y52.302-50.119
Compared to industry (Medical Distribution)
PeriodCompanyIndustry (mean)+/- 
EOD2.3316.313-3.982
MRQ2.0224.510-2.488
TTM11.8107.516+4.294
YOY-3.7435.255-8.998
5Y2.1832.484-0.301
10Y52.3021.762+50.540
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of China National Medicines Corp Ltd is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Medical Distribution industry mean).
  • A PB ratio of 1.23 means the investor is paying ¥1.23 for each ¥1 in book value.

Let's take a look of the Price to Book Ratio trends of China National Medicines Corp Ltd:

  • The EOD is 1.420. Based on the equity, the company is underpriced. +1
  • The MRQ is 1.232. Based on the equity, the company is underpriced. +1
  • The TTM is 1.559. Based on the equity, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD1.420MRQ1.232+0.188
MRQ1.232TTM1.559-0.328
TTM1.559YOY1.356+0.203
TTM1.5595Y1.950-0.391
5Y1.95010Y3.923-1.973
Compared to industry (Medical Distribution)
PeriodCompanyIndustry (mean)+/- 
EOD1.4201.110+0.310
MRQ1.2321.178+0.054
TTM1.5591.224+0.335
YOY1.3561.307+0.049
5Y1.9501.386+0.564
10Y3.9232.166+1.757
2. Total Gains per Share

3. Summary

3.1. Key Performance Indicators

The key performance indicators of China National Medicines Corp Ltd compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--0.9670.555+74%0.498+94%0.757+28%0.508+90%
Book Value Per Share--23.23822.194+5%20.103+16%17.537+33%12.077+92%
Current Ratio--2.0352.019+1%1.993+2%1.951+4%1.066+91%
Debt To Asset Ratio--0.4600.464-1%0.465-1%0.478-4%0.490-6%
Debt To Equity Ratio--0.9460.964-2%0.973-3%1.039-9%1.084-13%
Dividend Per Share--0.0290.235-88%0.222-87%0.193-85%0.163-82%
Eps--0.9060.711+27%0.651+39%0.556+63%0.403+125%
Free Cash Flow Per Share--3.5390.855+314%0.751+371%0.610+480%0.491+621%
Free Cash Flow To Equity Per Share--3.5390.570+521%0.617+473%0.373+848%0.434+715%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Intrinsic Value_10Y_max--161.139--------
Intrinsic Value_10Y_min--66.044--------
Intrinsic Value_1Y_max--4.879--------
Intrinsic Value_1Y_min--2.771--------
Intrinsic Value_3Y_max--23.248--------
Intrinsic Value_3Y_min--11.707--------
Intrinsic Value_5Y_max--51.969--------
Intrinsic Value_5Y_min--24.281--------
Market Cap24898598208.000+13%21593875802.76026005832083.565-17%20545116635.540+5%26296606873.232-18%25240456172.680-14%
Net Profit Margin--0.0520.043+21%0.043+20%0.039+34%0.039+34%
Operating Margin---0.022-100%0.049-100%0.042-100%0.023-100%
Operating Ratio--1.8561.871-1%1.8630%1.870-1%1.441+29%
Pb Ratio1.420+13%1.2321.559-21%1.356-9%1.950-37%3.923-69%
Pe Ratio9.104+13%7.89612.698-38%10.819-27%16.268-51%26.355-70%
Price Per Share33.000+13%28.62034.468-17%27.230+5%32.023-11%31.126-8%
Price To Free Cash Flow Ratio2.331+13%2.02211.810-83%-3.743+285%2.183-7%52.302-96%
Price To Total Gains Ratio33.113+13%28.71845.244-37%38.625-26%55.002-48%76.150-62%
Quick Ratio--0.6450.670-4%1.112-42%0.997-35%0.985-35%
Return On Assets--0.0210.017+23%0.017+22%0.017+28%0.018+16%
Return On Equity--0.0430.036+22%0.036+20%0.036+21%0.040+8%
Total Gains Per Share--0.9970.790+26%0.720+38%0.951+5%0.671+49%
Usd Book Value--2426588496.2342317554824.749+5%2099180318.791+16%1930009281.389+26%1340843186.818+81%
Usd Book Value Change Per Share--0.1340.077+74%0.069+94%0.105+28%0.070+90%
Usd Book Value Per Share--3.2163.072+5%2.782+16%2.427+33%1.671+92%
Usd Dividend Per Share--0.0040.033-88%0.031-87%0.027-85%0.023-82%
Usd Eps--0.1250.098+27%0.090+39%0.077+63%0.056+125%
Usd Free Cash Flow--369536629.96289321038.799+314%78381000.642+371%66655036.646+454%50724053.838+629%
Usd Free Cash Flow Per Share--0.4900.118+314%0.104+371%0.084+480%0.068+621%
Usd Free Cash Flow To Equity Per Share--0.4900.079+521%0.085+473%0.052+848%0.060+715%
Usd Market Cap3445965991.987+13%2988592411.1023599207160.365-17%2843444142.359+5%3639450391.255-18%3493279134.299-14%
Usd Price Per Share4.567+13%3.9614.770-17%3.769+5%4.432-11%4.308-8%
Usd Profit--94624475.86874251556.630+27%67956391.553+39%61247035.324+54%44770371.353+111%
Usd Revenue--1822226818.9381719483175.299+6%1574250998.243+16%1568669311.215+16%1172422252.390+55%
Usd Total Gains Per Share--0.1380.109+26%0.100+38%0.132+5%0.093+49%
 EOD+4 -4MRQTTM+27 -8YOY+28 -75Y+27 -810Y+26 -9

3.2. Fundamental Score

Let's check the fundamental score of China National Medicines Corp Ltd based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-159.104
Price to Book Ratio (EOD)Between0-11.420
Net Profit Margin (MRQ)Greater than00.052
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than10.645
Current Ratio (MRQ)Greater than12.035
Debt to Asset Ratio (MRQ)Less than10.460
Debt to Equity Ratio (MRQ)Less than10.946
Return on Equity (MRQ)Greater than0.150.043
Return on Assets (MRQ)Greater than0.050.021
Total5/10 (50.0%)

3.3. Technical Score

Let's check the technical score of China National Medicines Corp Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
OpenGreater thanClose31.660
Total0/1 (0.0%)



Reversals in quarterly reports

I have detected a reversal (positive to negative, negative to positive) in the following values of the quarterly reports.

 2022-12-312023-03-312023-06-302023-09-302023-12-31
Interest Expense  8,0675,25913,326-86312,463-3,0949,369-12,956-3,587



Latest Balance Sheet

Balance Sheet of 2023-12-31. Currency in CNY. All numbers in thousands.

Summary
Total Assets32,453,093
Total Liabilities14,919,939
Total Stockholder Equity15,775,888
 As reported
Total Liabilities 14,919,939
Total Stockholder Equity+ 15,775,888
Total Assets = 32,453,093

Assets

Total Assets32,453,093
Total Current Assets28,279,389
Long-term Assets4,173,704
Total Current Assets
Cash And Cash Equivalents 10,925,539
Net Receivables 8,959,092
Inventory 3,961,415
Other Current Assets 8,690
Total Current Assets  (as reported)28,279,389
Total Current Assets  (calculated)23,854,735
+/- 4,424,654
Long-term Assets
Property Plant Equipment 827,035
Goodwill 203,770
Intangible Assets 386,099
Long-term Assets Other 686,046
Long-term Assets  (as reported)4,173,704
Long-term Assets  (calculated)2,102,951
+/- 2,070,753

Liabilities & Shareholders' Equity

Total Current Liabilities13,894,453
Long-term Liabilities1,025,485
Total Stockholder Equity15,775,888
Total Current Liabilities
Short Long Term Debt 268,354
Accounts payable 10,943,060
Other Current Liabilities 1,204
Total Current Liabilities  (as reported)13,894,453
Total Current Liabilities  (calculated)11,212,618
+/- 2,681,836
Long-term Liabilities
Capital Lease Obligations Min Short Term Debt205,076
Long-term Liabilities Other 747,137
Long-term Liabilities  (as reported)1,025,485
Long-term Liabilities  (calculated)952,213
+/- 73,272
Total Stockholder Equity
Retained Earnings 12,034,397
Total Stockholder Equity (as reported)15,775,888
Total Stockholder Equity (calculated)12,034,397
+/- 3,741,491
Other
Capital Stock754,503
Common Stock Shares Outstanding 754,503
Net Invested Capital 16,044,241
Net Working Capital 14,384,936
Property Plant and Equipment Gross 827,035



Balance Sheet

Currency in CNY. All numbers in thousands.

 Trend2023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302012-03-312011-12-312011-09-302011-06-302011-03-312010-12-312010-09-302010-06-302010-03-312009-12-312009-09-302009-06-302009-03-312008-12-312008-09-302008-06-302008-03-312007-12-312007-09-302007-06-302007-03-312006-12-312006-09-302006-06-302006-03-312005-12-312005-09-302005-06-302005-03-312004-12-312004-09-302004-06-302004-03-312003-12-312003-09-302003-06-302003-03-312002-12-312002-06-302001-12-312000-12-31
> Total Assets 
382,829
435,764
469,801
808,371
850,839
970,720
993,177
1,088,449
1,037,768
995,158
1,043,975
1,192,863
1,149,815
1,164,971
1,276,287
1,280,598
1,262,233
1,270,442
1,363,163
1,362,047
1,566,529
1,635,643
1,807,327
1,955,981
1,876,000
2,031,693
2,053,959
1,996,873
2,072,199
2,185,940
2,426,859
2,776,797
2,949,311
2,943,609
3,227,392
3,392,770
3,271,709
3,526,498
3,337,663
3,551,674
3,766,176
4,054,215
4,263,137
4,559,270
4,338,792
4,539,887
4,983,476
5,079,239
5,055,358
5,103,618
5,698,847
5,537,856
5,551,468
5,662,076
5,910,497
6,556,054
6,418,802
6,603,844
6,980,746
7,401,463
7,458,562
18,351,953
19,327,319
20,165,955
20,522,241
20,408,140
20,833,920
21,509,768
20,968,592
22,092,623
24,264,517
24,193,651
23,706,860
23,502,099
24,796,633
24,904,933
24,667,367
26,460,230
27,524,919
27,475,018
27,401,128
27,059,095
29,318,178
29,609,042
29,973,102
30,839,517
31,631,632
32,453,093
32,453,09331,631,63230,839,51729,973,10229,609,04229,318,17827,059,09527,401,12827,475,01827,524,91926,460,23024,667,36724,904,93324,796,63323,502,09923,706,86024,193,65124,264,51722,092,62320,968,59221,509,76820,833,92020,408,14020,522,24120,165,95519,327,31918,351,9537,458,5627,401,4636,980,7466,603,8446,418,8026,556,0545,910,4975,662,0765,551,4685,537,8565,698,8475,103,6185,055,3585,079,2394,983,4764,539,8874,338,7924,559,2704,263,1374,054,2153,766,1763,551,6743,337,6633,526,4983,271,7093,392,7703,227,3922,943,6092,949,3112,776,7972,426,8592,185,9402,072,1991,996,8732,053,9592,031,6931,876,0001,955,9811,807,3271,635,6431,566,5291,362,0471,363,1631,270,4421,262,2331,280,5981,276,2871,164,9711,149,8151,192,8631,043,975995,1581,037,7681,088,449993,177970,720850,839808,371469,801435,764382,829
   > Total Current Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
18,770,249
19,323,293
18,851,430
19,794,859
21,832,164
21,676,007
21,161,238
20,747,562
22,001,474
22,109,586
21,817,554
23,689,738
24,685,975
24,456,822
24,314,009
23,808,790
25,963,274
25,764,118
26,044,106
26,983,832
27,669,874
28,279,389
28,279,38927,669,87426,983,83226,044,10625,764,11825,963,27423,808,79024,314,00924,456,82224,685,97523,689,73821,817,55422,109,58622,001,47420,747,56221,161,23821,676,00721,832,16419,794,85918,851,43019,323,29318,770,249000000000000000000000000000000000000000000000000000000000000000000
       Cash And Cash Equivalents 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
4,486,533
5,099,128
3,936,321
4,758,734
4,774,996
5,702,156
4,881,078
6,147,507
5,288,952
6,224,610
5,220,081
6,728,638
6,260,691
7,304,452
5,872,473
6,766,574
6,409,744
8,896,165
7,895,459
7,812,953
7,848,910
10,925,539
10,925,5397,848,9107,812,9537,895,4598,896,1656,409,7446,766,5745,872,4737,304,4526,260,6916,728,6385,220,0816,224,6105,288,9526,147,5074,881,0785,702,1564,774,9964,758,7343,936,3215,099,1284,486,533000000000000000000000000000000000000000000000000000000000000000000
       Short-term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
11,400
11,400
0
0
0
0
0
0
0
0
0000000011,40011,400000000000000000000000000000000000000000000000000000000000000000000000000000000
       Net Receivables 
133,374
181,131
211,416
228,589
248,830
226,052
289,657
298,226
322,182
318,740
357,024
342,976
384,644
364,309
446,890
388,459
459,690
445,004
514,270
469,338
579,612
598,119
680,118
659,842
721,777
751,952
738,753
743,200
817,288
889,726
1,015,799
896,973
934,773
1,026,148
1,078,173
968,380
1,166,759
1,250,872
1,394,126
1,532,364
1,680,367
1,701,747
1,953,868
1,733,444
1,755,905
1,963,635
2,138,682
2,135,804
2,051,167
2,327,890
2,453,442
2,524,294
2,401,752
2,566,631
2,675,926
2,627,171
2,705,751
2,802,890
3,095,244
3,199,549
3,094,265
9,817,407
10,677,763
9,907,029
10,191,941
10,417,384
10,776,183
10,553,109
10,204,307
10,380,050
11,478,902
12,296,561
11,251,805
10,855,752
13,271,863
12,636,753
12,801,989
13,319,065
14,745,431
13,503,478
14,074,924
13,177,631
15,569,318
12,940,090
5,751,179
15,122,180
6,467,078
8,959,092
8,959,0926,467,07815,122,1805,751,17912,940,09015,569,31813,177,63114,074,92413,503,47814,745,43113,319,06512,801,98912,636,75313,271,86310,855,75211,251,80512,296,56111,478,90210,380,05010,204,30710,553,10910,776,18310,417,38410,191,9419,907,02910,677,7639,817,4073,094,2653,199,5493,095,2442,802,8902,705,7512,627,1712,675,9262,566,6312,401,7522,524,2942,453,4422,327,8902,051,1672,135,8042,138,6821,963,6351,755,9051,733,4441,953,8681,701,7471,680,3671,532,3641,394,1261,250,8721,166,759968,3801,078,1731,026,148934,773896,9731,015,799889,726817,288743,200738,753751,952721,777659,842680,118598,119579,612469,338514,270445,004459,690388,459446,890364,309384,644342,976357,024318,740322,182298,226289,657226,052248,830228,589211,416181,131133,374
       Other Current Assets 
16,510
9,361
10,293
7,937
7,352
17,523
34,916
18,060
16,236
21,560
29,137
21,233
20,295
34,022
28,903
47,807
52,813
55,504
65,789
54,745
113,191
68,187
122,473
85,120
140,964
129,187
97,105
121,927
63,783
109,144
94,526
33,838
47,589
49,523
53,203
80,630
76,510
82,551
273,179
70,298
141,349
155,047
117,850
238,727
119,827
98,890
53,514
146,273
112,013
111,626
76,114
95,898
85,607
39,436
23,000
46,766
39,465
17,474
51,344
51,592
38,285
93,202
148,721
208,448
367,759
303,813
329,563
327,751
80,808
7,565
4,523
320,832
372,122
253,793
270,738
198,650
313,990
254,075
100,596
122,518
305,684
158,373
117,220
14,521
78,455
102,523
5,278
8,690
8,6905,278102,52378,45514,521117,220158,373305,684122,518100,596254,075313,990198,650270,738253,793372,122320,8324,5237,56580,808327,751329,563303,813367,759208,448148,72193,20238,28551,59251,34417,47439,46546,76623,00039,43685,60795,89876,114111,626112,013146,27353,51498,890119,827238,727117,850155,047141,34970,298273,17982,55176,51080,63053,20349,52347,58933,83894,526109,14463,783121,92797,105129,187140,96485,120122,47368,187113,19154,74565,78955,50452,81347,80728,90334,02220,29521,23329,13721,56016,23618,06034,91617,5237,3527,93710,2939,36116,510
   > Long-term Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
2,117,162
2,297,764
2,432,354
2,517,644
2,545,622
2,754,537
2,795,159
2,795,347
2,849,813
2,770,491
2,838,945
3,018,196
3,087,119
3,250,304
3,354,904
3,844,924
3,928,997
3,855,685
3,961,758
4,173,704
4,173,7043,961,7583,855,6853,928,9973,844,9243,354,9043,250,3043,087,1193,018,1962,838,9452,770,4912,849,8132,795,3472,795,1592,754,5372,545,6222,517,6442,432,3542,297,7642,117,16200000000000000000000000000000000000000000000000000000000000000000000
       Property Plant Equipment 
43,127
43,271
42,701
49,809
49,227
74,290
87,597
131,433
145,135
180,763
197,355
227,564
229,746
224,971
232,199
235,898
235,369
240,301
238,141
236,546
230,754
228,083
225,740
211,654
208,575
205,594
204,212
212,302
202,716
208,198
202,741
222,256
213,824
231,611
222,261
229,252
220,908
218,802
217,906
226,295
218,146
306,564
252,799
437,282
393,262
494,847
451,360
521,217
423,002
446,495
460,119
552,420
574,015
567,673
566,357
576,864
566,381
563,020
555,407
548,652
537,740
608,712
598,380
589,445
597,699
603,799
603,894
628,462
618,591
775,485
845,262
832,741
798,805
942,509
915,536
895,733
864,902
849,970
836,080
845,063
823,320
853,154
889,508
857,907
824,349
799,449
762,400
827,035
827,035762,400799,449824,349857,907889,508853,154823,320845,063836,080849,970864,902895,733915,536942,509798,805832,741845,262775,485618,591628,462603,894603,799597,699589,445598,380608,712537,740548,652555,407563,020566,381576,864566,357567,673574,015552,420460,119446,495423,002521,217451,360494,847393,262437,282252,799306,564218,146226,295217,906218,802220,908229,252222,261231,611213,824222,256202,741208,198202,716212,302204,212205,594208,575211,654225,740228,083230,754236,546238,141240,301235,369235,898232,199224,971229,746227,564197,355180,763145,135131,43387,59774,29049,22749,80942,70143,27143,127
       Goodwill 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
2,452
2,452
2,452
2,452
2,452
2,452
2,452
2,452
2,452
2,452
2,452
2,452
2,452
154,899
154,899
154,899
154,899
158,044
158,044
158,044
158,044
203,770
203,770
203,770
203,770
203,770
203,770
203,770
203,770
203,770
203,770
203,770
203,770
203,770
203,770
203,770
203,770
203,770
203,770
203,770
203,770203,770203,770203,770203,770203,770203,770203,770203,770203,770203,770203,770203,770203,770203,770203,770203,770203,770203,770158,044158,044158,044158,044154,899154,899154,899154,8992,4522,4522,4522,4522,4522,4522,4522,4522,4522,4522,4522,4522,452000000000000000000000000000000000000000000000000
       Long Term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
823,680
914,597
858,534
801,632
844,323
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000000000844,323801,632858,534914,597823,680000000000000000000000000000000000000000000000000000000000000000000
       Intangible Assets 
0
0
0
1,556
1,556
1,401
1,951
3,166
2,996
2,827
2,658
3,389
3,175
2,989
7,136
6,635
7,577
7,019
7,079
6,559
5,964
5,482
7,645
5,154
4,509
3,887
5,430
4,814
13,099
3,973
10,233
2,947
9,512
2,511
11,269
1,922
10,811
10,738
10,651
1,588
12,393
6,546
68,816
14,785
74,288
13,822
74,932
13,135
58,003
57,368
70,173
70,817
70,828
73,388
69,203
69,297
68,640
68,690
67,140
69,951
68,658
395,515
392,897
390,394
387,129
391,436
231,772
242,820
286,062
270,615
318,716
324,454
320,828
319,545
318,544
330,377
325,496
325,356
326,904
326,210
319,279
326,393
331,186
330,911
326,906
341,717
343,399
386,099
386,099343,399341,717326,906330,911331,186326,393319,279326,210326,904325,356325,496330,377318,544319,545320,828324,454318,716270,615286,062242,820231,772391,436387,129390,394392,897395,51568,65869,95167,14068,69068,64069,29769,20373,38870,82870,81770,17357,36858,00313,13574,93213,82274,28814,78568,8166,54612,3931,58810,65110,73810,8111,92211,2692,5119,5122,94710,2333,97313,0994,8145,4303,8874,5095,1547,6455,4825,9646,5597,0797,0197,5776,6357,1362,9893,1753,3892,6582,8272,9963,1661,9511,4011,5561,556000
       Long-term Assets Other 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
213,660
212,370
110,519
101,325
107,394
112,813
678,245
674,793
102,878
103,861
92,061
139,556
146,545
150,324
275,518
686,668
689,006
692,129
700,507
686,046
686,046700,507692,129689,006686,668275,518150,324146,545139,55692,061103,861102,878674,793678,245112,813107,394101,325110,519212,370213,66000000000000000000000000000000000000000000000000000000000000000000000
> Total Liabilities 
258,328
300,989
320,839
408,751
408,187
517,581
529,039
619,799
556,615
519,615
559,939
704,484
644,482
662,198
762,810
759,270
718,686
712,446
783,400
771,054
916,238
990,621
1,128,428
1,230,025
1,106,031
1,250,157
1,231,345
1,128,626
1,145,694
1,212,525
1,392,533
1,693,720
1,794,788
1,775,520
1,915,034
2,049,608
1,866,323
2,102,566
1,831,810
2,018,774
2,150,713
2,364,765
2,464,370
2,689,789
2,374,789
2,567,023
2,881,124
2,883,459
2,755,780
2,779,924
3,240,669
2,957,062
2,843,251
2,836,923
2,976,171
3,041,749
2,786,502
2,861,228
3,085,533
3,384,655
3,294,398
9,527,430
10,207,017
10,709,512
10,863,098
10,647,199
10,736,410
10,900,117
10,024,061
10,904,065
12,770,470
12,034,889
11,288,440
11,156,458
12,068,228
11,810,909
11,351,165
13,107,086
13,670,348
13,119,552
12,636,332
12,326,916
14,004,672
13,749,572
13,659,123
14,508,681
14,828,248
14,919,939
14,919,93914,828,24814,508,68113,659,12313,749,57214,004,67212,326,91612,636,33213,119,55213,670,34813,107,08611,351,16511,810,90912,068,22811,156,45811,288,44012,034,88912,770,47010,904,06510,024,06110,900,11710,736,41010,647,19910,863,09810,709,51210,207,0179,527,4303,294,3983,384,6553,085,5332,861,2282,786,5023,041,7492,976,1712,836,9232,843,2512,957,0623,240,6692,779,9242,755,7802,883,4592,881,1242,567,0232,374,7892,689,7892,464,3702,364,7652,150,7132,018,7741,831,8102,102,5661,866,3232,049,6081,915,0341,775,5201,794,7881,693,7201,392,5331,212,5251,145,6941,128,6261,231,3451,250,1571,106,0311,230,0251,128,428990,621916,238771,054783,400712,446718,686759,270762,810662,198644,482704,484559,939519,615556,615619,799529,039517,581408,187408,751320,839300,989258,328
   > Total Current Liabilities 
258,328
300,989
317,839
405,751
408,187
517,582
529,039
567,799
504,615
467,615
507,939
647,484
544,544
562,260
665,872
713,132
674,548
678,553
749,506
736,961
875,520
957,447
1,095,254
1,188,968
1,066,435
1,211,413
1,194,377
1,091,242
1,108,524
1,171,009
1,351,520
1,363,074
1,426,801
1,399,336
1,490,342
1,592,050
1,397,990
1,634,701
1,366,111
1,672,778
2,014,843
2,224,295
2,319,070
2,511,174
2,201,366
2,395,898
2,710,812
2,720,241
2,492,654
2,538,524
2,985,331
2,715,333
2,601,615
2,594,820
2,734,160
2,886,740
2,633,569
2,709,785
2,936,215
3,237,858
3,148,776
9,274,562
9,934,157
10,465,057
10,621,681
10,407,367
10,499,399
10,625,174
9,757,483
10,509,862
12,306,432
11,603,287
10,889,880
10,575,256
11,383,607
11,237,145
10,797,812
12,569,390
13,163,088
12,628,485
12,162,736
11,824,828
13,400,595
12,739,590
12,676,622
13,536,162
13,877,485
13,894,453
13,894,45313,877,48513,536,16212,676,62212,739,59013,400,59511,824,82812,162,73612,628,48513,163,08812,569,39010,797,81211,237,14511,383,60710,575,25610,889,88011,603,28712,306,43210,509,8629,757,48310,625,17410,499,39910,407,36710,621,68110,465,0579,934,1579,274,5623,148,7763,237,8582,936,2152,709,7852,633,5692,886,7402,734,1602,594,8202,601,6152,715,3332,985,3312,538,5242,492,6542,720,2412,710,8122,395,8982,201,3662,511,1742,319,0702,224,2952,014,8431,672,7781,366,1111,634,7011,397,9901,592,0501,490,3421,399,3361,426,8011,363,0741,351,5201,171,0091,108,5241,091,2421,194,3771,211,4131,066,4351,188,9681,095,254957,447875,520736,961749,506678,553674,548713,132665,872562,260544,544647,484507,939467,615504,615567,799529,039517,582408,187405,751317,839300,989258,328
       Short-term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1,064,137
578,746
480,652
348,922
1,016,530
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000001,016,530348,922480,652578,7461,064,13700000000000000000000000000000000000000000000000000000000000000000000
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1,064,137
578,746
480,652
348,922
1,016,530
683,886
541,181
471,834
506,056
463,857
553,260
428,827
151,126
300,604
301,262
252,059
252,861
216,315
222,812
268,354
268,354222,812216,315252,861252,059301,262300,604151,126428,827553,260463,857506,056471,834541,181683,8861,016,530348,922480,652578,7461,064,13700000000000000000000000000000000000000000000000000000000000000000000
       Accounts payable 
122,508
151,630
169,349
205,938
234,767
274,580
272,301
336,339
270,252
283,138
290,012
363,554
264,875
327,938
425,027
414,148
398,149
431,673
488,825
468,631
551,112
730,372
864,632
673,773
628,896
933,168
936,134
937,560
967,615
1,014,873
1,225,411
1,268,838
1,324,716
1,308,136
1,363,953
1,485,546
1,294,032
1,573,787
1,291,208
1,513,288
1,684,166
1,766,445
1,970,422
2,060,518
1,794,720
1,903,462
2,033,487
1,932,154
1,803,215
1,875,593
2,343,398
2,126,980
2,036,989
1,985,582
2,161,129
2,204,164
2,272,924
2,308,942
2,616,683
2,836,862
2,836,788
6,862,998
7,543,881
7,767,163
8,084,888
8,115,958
8,669,788
8,157,247
7,739,739
8,589,344
10,525,036
9,403,921
8,527,126
8,413,828
9,455,589
8,990,328
8,248,741
9,870,337
10,366,143
10,057,810
10,001,580
9,427,256
10,829,772
9,916,659
9,875,532
11,189,425
11,421,791
10,943,060
10,943,06011,421,79111,189,4259,875,5329,916,65910,829,7729,427,25610,001,58010,057,81010,366,1439,870,3378,248,7418,990,3289,455,5898,413,8288,527,1269,403,92110,525,0368,589,3447,739,7398,157,2478,669,7888,115,9588,084,8887,767,1637,543,8816,862,9982,836,7882,836,8622,616,6832,308,9422,272,9242,204,1642,161,1291,985,5822,036,9892,126,9802,343,3981,875,5931,803,2151,932,1542,033,4871,903,4621,794,7202,060,5181,970,4221,766,4451,684,1661,513,2881,291,2081,573,7871,294,0321,485,5461,363,9531,308,1361,324,7161,268,8381,225,4111,014,873967,615937,560936,134933,168628,896673,773864,632730,372551,112468,631488,825431,673398,149414,148425,027327,938264,875363,554290,012283,138270,252336,339272,301274,580234,767205,938169,349151,630122,508
       Other Current Liabilities 
73,480
95,019
84,150
107,873
93,480
131,402
145,138
104,860
107,763
103,477
106,927
135,319
86,981
90,863
83,845
179,785
174,399
177,880
191,681
128,330
239,961
224,628
229,795
383,183
246,280
138,242
220,111
148,989
135,202
151,275
122,216
75,520
90,911
91,200
126,389
106,504
103,958
60,914
74,903
159,490
130,677
207,850
232,748
300,656
256,646
242,436
327,325
388,087
339,439
312,931
291,933
288,353
264,625
309,238
273,032
382,577
260,645
300,842
319,532
400,995
311,988
930,065
1,030,689
1,461,520
826,083
971,984
1,076,586
1,093,706
52,746
54,908
49,842
1,196,783
1,167,119
921,147
1,224,131
1,190,432
1,856,994
1,442,281
2,031,218
1,502,007
1,793,977
1,603,452
2,055,394
1,020
2,407,863
1,861,970
2,640
1,204
1,2042,6401,861,9702,407,8631,0202,055,3941,603,4521,793,9771,502,0072,031,2181,442,2811,856,9941,190,4321,224,131921,1471,167,1191,196,78349,84254,90852,7461,093,7061,076,586971,984826,0831,461,5201,030,689930,065311,988400,995319,532300,842260,645382,577273,032309,238264,625288,353291,933312,931339,439388,087327,325242,436256,646300,656232,748207,850130,677159,49074,90360,914103,958106,504126,38991,20090,91175,520122,216151,275135,202148,989220,111138,242246,280383,183229,795224,628239,961128,330191,681177,880174,399179,78583,84590,86386,981135,319106,927103,477107,763104,860145,138131,40293,480107,87384,15095,01973,480
   > Long-term Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
266,579
394,203
464,038
431,601
398,561
581,202
684,621
573,764
553,353
537,696
507,260
491,066
473,596
502,088
604,077
1,009,982
982,501
972,519
950,764
1,025,485
1,025,485950,764972,519982,5011,009,982604,077502,088473,596491,066507,260537,696553,353573,764684,621581,202398,561431,601464,038394,203266,57900000000000000000000000000000000000000000000000000000000000000000000
       Other Liabilities 
0
0
0
0
0
0
0
52,000
52,000
52,000
52,000
52,000
94,938
94,938
94,938
44,138
44,138
33,893
33,894
34,093
33,175
33,174
33,174
41,057
39,596
32,975
32,975
32,975
32,975
32,975
32,974
319,411
356,440
367,250
408,651
457,558
468,333
467,865
465,699
345,996
135,870
140,470
145,300
175,208
170,108
167,903
167,183
160,181
160,182
138,549
152,579
139,062
139,062
139,623
139,623
152,713
150,730
149,333
147,300
144,873
143,790
208,433
229,350
201,870
199,756
197,642
237,011
233,233
238,772
250,195
247,870
264,982
268,794
269,668
408,808
313,678
311,249
307,435
293,288
293,776
293,049
306,497
398,679
0
0
820,923
0
0
00820,92300398,679306,497293,049293,776293,288307,435311,249313,678408,808269,668268,794264,982247,870250,195238,772233,233237,011197,642199,756201,870229,350208,433143,790144,873147,300149,333150,730152,713139,623139,623139,062139,062152,579138,549160,182160,181167,183167,903170,108175,208145,300140,470135,870345,996465,699467,865468,333457,558408,651367,250356,440319,41132,97432,97532,97532,97532,97532,97539,59641,05733,17433,17433,17534,09333,89433,89344,13844,13894,93894,93894,93852,00052,00052,00052,00052,0000000000
       Deferred Long Term Liability 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
67,307
56,827
58,452
58,600
63,022
71,806
74,848
80,683
89,594
90,308
93,286
96,942
98,277
89,605
89,464
73,235
81,692
0
0
109,494
0
0
00109,4940081,69273,23589,46489,60598,27796,94293,28690,30889,59480,68374,84871,80663,02258,60058,45256,82767,307000000000000000000000000000000000000000000000000000000000000000000
> Total Stockholder Equity
122,713
132,569
147,258
398,298
408,967
419,107
428,343
433,072
445,608
441,587
450,436
457,706
475,947
475,112
487,235
497,552
521,274
523,384
545,432
559,193
614,447
610,839
644,362
691,525
734,757
745,308
785,078
831,265
888,765
933,801
994,796
1,043,273
1,114,074
1,130,558
1,273,897
1,304,470
1,365,174
1,382,172
1,463,443
1,488,975
1,557,615
1,632,495
1,735,508
1,795,749
1,884,059
1,889,871
2,017,540
2,107,249
2,210,258
2,229,334
2,361,331
2,480,053
2,605,195
2,720,146
2,823,469
3,029,764
3,152,914
3,258,489
3,404,744
3,521,878
3,657,674
7,607,780
7,890,645
8,181,194
8,435,564
8,467,447
8,781,165
9,232,394
9,523,569
9,684,957
10,000,623
10,537,090
10,778,152
10,685,602
11,067,445
11,443,638
11,736,298
11,791,052
12,324,726
12,779,970
13,153,620
13,116,794
13,680,915
14,214,808
14,633,317
14,609,776
15,087,742
15,775,888
15,775,88815,087,74214,609,77614,633,31714,214,80813,680,91513,116,79413,153,62012,779,97012,324,72611,791,05211,736,29811,443,63811,067,44510,685,60210,778,15210,537,09010,000,6239,684,9579,523,5699,232,3948,781,1658,467,4478,435,5648,181,1947,890,6457,607,7803,657,6743,521,8783,404,7443,258,4893,152,9143,029,7642,823,4692,720,1462,605,1952,480,0532,361,3312,229,3342,210,2582,107,2492,017,5401,889,8711,884,0591,795,7491,735,5081,632,4951,557,6151,488,9751,463,4431,382,1721,365,1741,304,4701,273,8971,130,5581,114,0741,043,273994,796933,801888,765831,265785,078745,308734,757691,525644,362610,839614,447559,193545,432523,384521,274497,552487,235475,112475,947457,706450,436441,587445,608433,072428,343419,107408,967398,298147,258132,569122,713
   Common Stock
80,000
80,000
80,000
133,000
133,000
133,000
133,000
133,000
133,000
133,000
133,000
133,000
133,000
133,000
133,000
133,000
133,000
133,000
133,000
133,000
133,000
133,000
133,000
133,000
133,000
239,400
239,400
239,400
239,400
478,800
478,800
478,800
478,800
478,800
478,800
478,800
478,800
478,800
478,800
478,800
478,800
478,800
478,800
478,800
478,800
478,800
478,800
478,800
478,800
478,800
478,800
478,800
478,800
478,800
478,800
478,800
478,800
478,800
478,800
478,800
478,800
766,934
766,934
766,934
766,934
766,934
766,934
764,404
764,404
764,404
764,404
754,503
754,503
754,503
754,503
754,503
754,503
754,503
754,503
754,503
754,503
754,503
754,503
0
0
754,503
0
0
00754,50300754,503754,503754,503754,503754,503754,503754,503754,503754,503754,503754,503754,503764,404764,404764,404764,404766,934766,934766,934766,934766,934766,934478,800478,800478,800478,800478,800478,800478,800478,800478,800478,800478,800478,800478,800478,800478,800478,800478,800478,800478,800478,800478,800478,800478,800478,800478,800478,800478,800478,800478,800478,800478,800478,800239,400239,400239,400239,400133,000133,000133,000133,000133,000133,000133,000133,000133,000133,000133,000133,000133,000133,000133,000133,000133,000133,000133,000133,000133,000133,00080,00080,00080,000
   Retained Earnings Total Equity0000000000000000000000000000000000000000000000000000000000000000000000000000000000000000
   Accumulated Other Comprehensive Income 0000000000000000000000000000000000000000000000000000000000000000000000000000000000000000
   Capital Surplus 0000000000000000000000000000000000000000000000000000000000000000000000000000000000000000
   Treasury Stock0000000000000000000000000000000000000000000000000000000000000000000000000000000000000000
   Other Stockholders Equity 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
18,273
15,894
20,622
19,608
18,567
22,453
31,543
32,499
29,404
27,685
22,536
24,224
22,142
24,910
24,713
27,639
22,377
0
0
26,574
0
0
0026,5740022,37727,63924,71324,91022,14224,22422,53627,68529,40432,49931,54322,45318,56719,60820,62215,89418,273000000000000000000000000000000000000000000000000000000000000000000



Balance Sheet

Currency in CNY. All numbers in thousands.




Cash Flow

Currency in CNY. All numbers in thousands.




Income Statement

Currency in CNY. All numbers in thousands.


Latest Income Statement (annual, 2023-12-31)

Gross Profit (+$)
totalRevenue49,696,046
Cost of Revenue-45,704,776
Gross Profit3,991,2693,991,269
 
Operating Income (+$)
Gross Profit3,991,269
Operating Expense-47,238,891
Operating Income2,457,155-43,247,621
 
Operating Expense (+$)
Research Development71,197
Selling General Administrative1,032,765
Selling And Marketing Expenses0
Operating Expense47,238,8911,103,963
 
Net Interest Income (+$)
Interest Income166,372
Interest Expense-31,570
Other Finance Cost-9,228
Net Interest Income125,574
 
Pretax Income (+$)
Operating Income2,457,155
Net Interest Income125,574
Other Non-Operating Income Expenses0
Income Before Tax (EBT)2,930,8902,457,155
EBIT - interestExpense = -31,570
2,145,999
2,177,569
Interest Expense31,570
Earnings Before Interest and Taxes (EBIT)02,962,460
Earnings Before Interest and Taxes (EBITDA)0
 
After tax Income (+$)
Income Before Tax2,930,890
Tax Provision-596,420
Net Income From Continuing Ops2,334,4712,334,471
Net Income2,145,999
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses0
Total Other Income/Expenses Net0-125,574
 

Technical Analysis of China National Medicines Corp Ltd
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of China National Medicines Corp Ltd. The general trend of China National Medicines Corp Ltd is UNKNOWN with 0.0% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine China National Medicines Corp Ltd's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator StateBullish trend Bearish trend
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of China National Medicines Corp Ltd.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 33.33 < 33.70 < 33.75.

The bearish price targets are: 29.43 > 27.30 > 27.18.

Tweet this
China National Medicines Corp Ltd Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of China National Medicines Corp Ltd. The current mas is .

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

China National Medicines Corp Ltd Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of China National Medicines Corp Ltd.

China National Medicines Corp Ltd Daily Moving Average Convergence/Divergence (MACD) ChartChina National Medicines Corp Ltd Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of China National Medicines Corp Ltd. The current adx is .

China National Medicines Corp Ltd Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of China National Medicines Corp Ltd.

China National Medicines Corp Ltd Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of China National Medicines Corp Ltd.

China National Medicines Corp Ltd Daily Relative Strength Index (RSI) ChartChina National Medicines Corp Ltd Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of China National Medicines Corp Ltd.

China National Medicines Corp Ltd Daily Stochastic Oscillator ChartChina National Medicines Corp Ltd Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of China National Medicines Corp Ltd.

China National Medicines Corp Ltd Daily Commodity Channel Index (CCI) ChartChina National Medicines Corp Ltd Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of China National Medicines Corp Ltd.

China National Medicines Corp Ltd Daily Chande Momentum Oscillator (CMO) ChartChina National Medicines Corp Ltd Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of China National Medicines Corp Ltd.

China National Medicines Corp Ltd Daily Williams %R ChartChina National Medicines Corp Ltd Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of China National Medicines Corp Ltd.

China National Medicines Corp Ltd Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of China National Medicines Corp Ltd.

China National Medicines Corp Ltd Daily Average True Range (ATR) ChartChina National Medicines Corp Ltd Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of China National Medicines Corp Ltd.

China National Medicines Corp Ltd Daily On-Balance Volume (OBV) ChartChina National Medicines Corp Ltd Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of China National Medicines Corp Ltd.

China National Medicines Corp Ltd Daily Money Flow Index (MFI) ChartChina National Medicines Corp Ltd Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for China National Medicines Corp Ltd.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-11-06STOCH SHORT EXITThe %K line crosses above the %D line.
2023-11-08MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2023-11-14WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2023-11-16STOCH LONG EXITThe %K line crosses below the %D line.
2023-11-20STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2023-11-21CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2023-11-22STOCH LONG EXITThe %K line crosses below the %D line.
2023-11-23DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2023-11-24BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2023-11-27STOCH LONG EXITThe %K line crosses below the %D line.
2023-11-28DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2023-11-29DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2023-11-30STOCH LONG EXITThe %K line crosses below the %D line.
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-06SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-12-07DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-12-08MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2023-12-11STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-13CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-12-14STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-12-15CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2023-12-20STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-21CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2023-12-22STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-25STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-26STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-27STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-29MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-01-02DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-01-03CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-01-04BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-01-05STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-09STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-10CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-01-11STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-15STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-01-17STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-18DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-19SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-22MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-24STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-25MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-29STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-01DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-02MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-02-05STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-06DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-07MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-08STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-20STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-02-21STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-22STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-26STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-29STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-04STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-05MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-03-06DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-08SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-13CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-03-14STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-15CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-03-18STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-19STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-20CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-03-21DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-22SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-03-25MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-27STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-03-28STOCH LONG EXITThe %K line crosses below the %D line.

6.3. Candlestick Patterns

China National Medicines Corp Ltd Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of China National Medicines Corp Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
OpenGreater thanClose31.660
Total0/1 (0.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of China National Medicines Corp Ltd with someone you think should read this too:
  • Are you bullish or bearish on China National Medicines Corp Ltd? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about China National Medicines Corp Ltd? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about China National Medicines Corp Ltd

I send you an email if I find something interesting about China National Medicines Corp Ltd.


Comments

How you think about this?

Leave a comment

Stay informed about China National Medicines Corp Ltd.

Receive notifications about China National Medicines Corp Ltd in your mailbox!